%D8%AA%D8%B6%D8%AE%D9%85_%D8%A7%D9%84%D8%A8%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA_%D8%A7%D9%84%D8%AD%D9%85%D9%8A%D8%AFHiperpl%C3%A0sia_benigna_de_pr%C3%B2stataCategory:Benign_prostatic_hyperplasiaBenign%C3%AD_hyperplazie_prostatyProstatavergr%C3%B6%C3%9Ferung%DE%95%DE%B0%DE%83%DE%AE%DE%90%DE%B0%DE%93%DE%AD%DE%93%DE%B0_%DE%87%DE%A7%DE%8B%DE%A6%DE%94%DE%A7_%DE%9A%DE%A8%DE%8D%DE%A7%DE%8A%DE%A6%DE%81%DE%B0_%DE%84%DE%AE%DE%91%DE%AA%DE%88%DE%AA%DE%82%DE%B0%CE%9A%CE%B1%CE%BB%CE%BF%CE%AE%CE%B8%CE%B7%CF%82_%CF%85%CF%80%CE%B5%CF%81%CF%80%CE%BB%CE%B1%CF%83%CE%AF%CE%B1_%CF%80%CF%81%CE%BF%CF%83%CF%84%CE%AC%CF%84%CE%B7Benign_prostatic_hyperplasiaHiperplasia_benigna_de_pr%C3%B3stataProstatako_hiperplasia_onbera%D9%87%D8%A7%DB%8C%D9%BE%D8%B1%D9%BE%D9%84%D8%A7%D8%B2%DB%8C_%D8%AE%D9%88%D8%B4%E2%80%8C%D8%AE%DB%8C%D9%85_%D9%BE%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AAEturauhasen_liikakasvuHypertrophie_b%C3%A9nigne_de_la_prostate%D7%94%D7%92%D7%93%D7%9C%D7%94_%D7%A9%D7%A4%D7%99%D7%A8%D7%94_%D7%A9%D7%9C_%D7%94%D7%A2%D7%A8%D7%9E%D7%95%D7%A0%D7%99%D7%AA%D5%87%D5%A1%D5%A3%D5%A1%D5%B6%D5%A1%D5%AF%D5%A1%D5%A3%D5%A5%D5%B2%D5%B1%D5%AB_%D5%A2%D5%A1%D6%80%D5%B8%D6%80%D5%A1%D5%AF_%D5%A3%D5%A5%D6%80%D5%A1%D5%B3Hiperplasia_prostat_jinakIperplasia_prostatica_benigna%E5%89%8D%E7%AB%8B%E8%85%BA%E8%82%A5%E5%A4%A7%E7%97%87%E1%83%9E%E1%83%A0%E1%83%9D%E1%83%A1%E1%83%A2%E1%83%90%E1%83%A2%E1%83%98%E1%83%A1_%E1%83%99%E1%83%94%E1%83%97%E1%83%98%E1%83%9A%E1%83%97%E1%83%95%E1%83%98%E1%83%A1%E1%83%94%E1%83%91%E1%83%98%E1%83%90%E1%83%9C%E1%83%98_%E1%83%B0%E1%83%98%E1%83%9E%E1%83%94%E1%83%A0%E1%83%9E%E1%83%9A%E1%83%90%E1%83%96%E1%83%98%E1%83%90%EC%A0%84%EB%A6%BD%EC%84%A0%EB%B9%84%EB%8C%80%EC%A6%9D%D0%9F%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B0_%D0%B1%D0%B5%D0%B7%D0%B8%D0%BD%D0%B8%D0%BD_%D0%B0%D0%B4%D0%B5%D0%BD%D0%BE%D0%BC%D0%B0%D1%81%D1%8BProstatos_adenoma%D0%91%D0%B5%D0%BD%D0%B8%D0%B3%D0%BD%D0%B0_%D1%85%D0%B8%D0%BF%D0%B5%D1%80%D0%BF%D0%BB%D0%B0%D0%B7%D0%B8%D1%98%D0%B0_%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B0%D1%82%D0%B0Hiperplasia_prostat_benignaBenigne_prostaathyperplasieGodarta_prostataforst%C3%B8rringGodartet_prostataforst%C3%B8rrelse%E0%AC%AC%E0%AC%BF%E0%AC%A8%E0%AC%BE%E0%AC%87%E0%AC%A8_%E0%AC%AA%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AD%8D%E0%AC%9F%E0%AC%BE%E0%AC%9F%E0%AC%BF%E0%AC%95_%E0%AC%B9%E0%AC%BE%E0%AC%87%E0%AC%AA%E0%AC%B0%E0%AC%AA%E0%AD%8D%E0%AC%B2%E0%AC%BE%E0%AC%B8%E0%AC%BF%E0%AC%86%C5%81agodny_rozrost_gruczo%C5%82u_krokowegoHiperplasia_benigna_da_pr%C3%B3stataHiperplazia_benign%C4%83_de_prostat%C4%83%D0%94%D0%BE%D0%B1%D1%80%D0%BE%D0%BA%D0%B0%D1%87%D0%B5%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D0%B0%D1%8F_%D0%B3%D0%B8%D0%BF%D0%B5%D1%80%D0%BF%D0%BB%D0%B0%D0%B7%D0%B8%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D0%BD%D0%BE%D0%B9_%D0%B6%D0%B5%D0%BB%D0%B5%D0%B7%D1%8BBenigno_uve%C4%87anje_prostateBen%C3%ADgna_hyperpl%C3%A1zia_prostaty%D0%91%D0%B5%D0%BD%D0%B8%D0%B3%D0%BD%D0%BE_%D1%83%D0%B2%D0%B5%D1%9B%D0%B0%D1%9A%D0%B5_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B5Benign_prostatahyperplasi%E0%AE%A4%E0%AF%80%E0%AE%A4%E0%AE%BF%E0%AE%B2%E0%AE%BF_%E0%AE%AE%E0%AF%81%E0%AE%A9%E0%AF%8D%E0%AE%A9%E0%AE%BF%E0%AE%B1%E0%AF%8D%E0%AE%95%E0%AF%81%E0%AE%9E%E0%AF%8D%E0%AE%9A%E0%AF%81%E0%AE%B0%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%BF_%E0%AE%AE%E0%AE%BF%E0%AE%95%E0%AF%88%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%86%E0%AE%B0%E0%AF%81%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AE%AE%E0%AF%8D%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%80%E0%B8%88%E0%B8%A3%E0%B8%B4%E0%B8%8D%E0%B9%80%E0%B8%81%E0%B8%B4%E0%B8%99%E0%B8%82%E0%B8%AD%E0%B8%87%E0%B8%95%E0%B9%88%E0%B8%AD%E0%B8%A1%E0%B8%A5%E0%B8%B9%E0%B8%81%E0%B8%AB%E0%B8%A1%E0%B8%B2%E0%B8%81%D0%94%D0%BE%D0%B1%D1%80%D0%BE%D1%8F%D0%BA%D1%96%D1%81%D0%BD%D0%B0_%D0%B3%D1%96%D0%BF%D0%B5%D1%80%D0%BF%D0%BB%D0%B0%D0%B7%D1%96%D1%8F_%D0%BF%D0%B5%D1%80%D0%B5%D0%B4%D0%BC%D1%96%D1%85%D1%83%D1%80%D0%BE%D0%B2%D0%BE%D1%97_%D0%B7%D0%B0%D0%BB%D0%BE%D0%B7%D0%B8Prostata_bezi_adenomasi
about
Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an updateRisk of acute myocardial infarction after transurethral resection of prostate in elderlyTestosterone and benign prostatic hyperplasiaα1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?Oxidative stress in prostate hyperplasia and carcinogenesisGenetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.Recent advances in the surgical treatment of benign prostatic hyperplasia.Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasiaThe impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.Diagnostic value of urodynamic bladder outlet obstruction to select patients for transurethral surgery of the prostate: Systematic review and meta-analysisThe Association Between Metabolic Syndrome and Characteristics of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasiaToll-like receptors in prostate infection and cancer between bench and bedsideA new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review.Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.Recent advances in managing benign prostatic hyperplasia: The Rezūm SystemEffects of Isoflavone in Patients With Watchful Waiting Benign Prostate HyperplasiaProstatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized PatientsEfficacy And Safety Study Of Naftopidil to Patients Treatment With LUTSCombination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)Duke Urology Database and Specimen BankA Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic HyperplasiaAssessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic HyperplasiaEvaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate EnlargementPharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate HyperplasiaExplorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate CancersStudy of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia (2005-06-30)Early Removal of the Urethral Catheter Following Trans-urethral Resection of Prostate
P921
Q1759552-2751C02A-32BC-4FEC-9A6C-2F9047C71E81Q2736873-58099A44-95F8-4A5A-9EA4-7F468E96C67EQ2736873-87C4AE7B-155A-4197-A300-113D32BBACDDQ280786-7E3DAD2E-57C4-4A4A-B1A0-92154A304F6BQ408963-63137749-29FF-4C4A-864A-DC7BFCE75021Q418480-92550FD0-FB44-44A6-A4BD-7063A372EC1EQ419939-B8F508FD-9D3A-4578-A13B-32A645644AA9Q419939-E754B9E6-118F-49D0-B7CE-07B29634542CQ424156-4763D5C5-9944-4CEB-9555-8FD48369D539Q424156-C64E50C3-9865-4A16-BCB7-7CB2EFF31805Q424167-8218BFCA-1AB0-4870-B30B-761597C90DB3Q424760-E1606699-5B61-4DCB-B225-30A73FB80799Q425296-E583C762-1A91-4C5B-9412-C3515A1D5F81Q49000812-c25ab383-4f52-b828-4be7-4ad947021fa1Q907160-77C53746-2D21-4AF6-8EB9-8A9EF92A8D67
P2175
description
Krankheit
@de
Proceso normal fisiólogico deb ...... y varios tratamientos posibles
@es
condizione clinica in cui vi è un ingrossamento della prostata
@it
noncancerous increase in size of the prostate
@en
pathologie masculine
@fr
sashvilosnos kelis hoperplazia
@ka
tăng kích thước tuyến tiền liệt không ung thư
@vi
مرض يصيب الإنسان
@ar
前列腺肿大
@zh
name
BPH
@id
Benign prostatic hyperplasia
@en-ca
Benign prostatic hyperplasia
@en-gb
Benigne Prostatahyperplasie
@de-ch
Benigno uvećanje prostate
@sh
Benigno uvećanje prostate
@sr-el
Eturauhasen liikakasvu
@fi
Godartet prostataforstørrelse
@nb
Hiperplasia prostat benigna
@ms
Hiperplasia prostática benigna
@pt-br
type
label
BPH
@id
Benign prostatic hyperplasia
@en-ca
Benign prostatic hyperplasia
@en-gb
Benigne Prostatahyperplasie
@de-ch
Benigno uvećanje prostate
@sh
Benigno uvećanje prostate
@sr-el
Eturauhasen liikakasvu
@fi
Godartet prostataforstørrelse
@nb
Hiperplasia prostat benigna
@ms
Hiperplasia prostática benigna
@pt-br
altLabel
Adenoma de prostata
@es
Adenoma de próstata
@es
Adénome de la prostate
@fr
Adénome de prostate
@fr
Adénome prostatique
@fr
BEP
@en
BEP
@zh
BHP
@cs
BPE
@en
BPE
@zh
prefLabel
BPH
@id
Benign prostatic hyperplasia
@en-ca
Benign prostatic hyperplasia
@en-gb
Benigne Prostatahyperplasie
@de-ch
Benigno uvećanje prostate
@sh
Benigno uvećanje prostate
@sr-el
Eturauhasen liikakasvu
@fi
Godartet prostataforstørrelse
@nb
Hiperplasia prostat benigna
@ms
Hiperplasia prostática benigna
@pt-br
P1692
P2176
P279
P699
P227
P349
P646
P1417
topic/benign-prostatic-hyperplasia
P1461
benign-prostatic-hyperplasia